Drug Trial Radar · NCT00071331
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
Last checked: Nov 19, 2026Latest source record: May 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,600
Actual
Start
Sep 2003
Primary completion
Jul 2006
Study completion Jul 2006
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Oct 21, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness of tolvaptan or placebo in adults with worsening congestive heart failure (CHF).
Conditions
- Congestive Heart Failure
Interventions
TolvaptanDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
378 sites in 18 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
The Heart Center
Huntsville, Alabama
The Heart Group
Mobile, Alabama
Phoenix Memorial Hospital
Gilbert, Arizona
Arizona Heart Institute
Phoenix, Arizona
Saguaro Clinical Research
Tucson, Arizona
Central Arkansas Veterans Healthcare Systems
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Bakersfield Memorial Hospital
Bakersfield, California
Central Cardiology Medical Center
Bakersfield, California
Cardiology Associates
Larkspur, California
Loma Linda University Medical Center
Loma Linda, California
LAC/USC Medical Center
Los Angeles, California
VA Medical Center- W. Los Angeles
Los Angeles, California
Mission Internal Medical Group
Mission Viejo, California
ARI Clinical Trials
Redondo Beach, California
San Diego Cardiac Center
San Diego, California
Pacific Heart Institute
Santa Monica, California
Cardiovascular Consultants Medical Group, Inc.
Walnut Creek, California
Aurora Denver Cardiology Associates
Denver, Colorado
University of Colorado
Denver, Colorado
Heart and Vascular Clinic of North Colorado
Fort Collins, Colorado
Bakus Resesarch
Norwich, Connecticut
Christiana Care Health System
Newark, Delaware
VA Medical Center
Washington D.C., District of Columbia
Florida Cardiovascular Research
Atlantis, Florida
Cardiology Associates of Fort Lauderdale
Fort Lauderdale, Florida
Jacksonville Heart Center
Jacksonville, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Jacksonville Heart Center
Jacksonville Beach, Florida
Melbourne Internal Medicine Assoc.
Melbourne, Florida
University of Miami/ Jackson Memorial Hospital
Miami, Florida
Miami Research and Education Foundation
Miami, Florida
Ocala Resarch Institute
Ocala, Florida
Cardiology Research Associates
Ormond Beach, Florida
Charlotte Heart Group Research Center
Port Charlotte, Florida
Cardiovascular Center of Sarasota
Sarasota, Florida
The Heart and Vascular Institute of Florida
St. Petersburg, Florida
Cardiac Disease Specialists PC
Atlanta, Georgia
Atlanta Heart and Vascular Research Group
Atlanta, Georgia
Showing 40 of 378 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.